Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
Horse immune response of recombinant Lawsonia intracellularis vaccine: Assessing the immunomodulatory impact of probiotic supplementation.
Research in veterinary science    March 2, 2026   Volume 204 106132 doi: 10.1016/j.rvsc.2026.106132
Conrad NL, Mazzoleni I, Abreu MC, Costa AV, Di Giácomo CP, Zorzi VSG, Leite FPL.Equine proliferative enteropathy (EPE), caused by Lawsonia intracellularis induces intestinal epithelial hyperplasia, resulting in malabsorption, weight loss, colic, and diarrhea. Despite its clinical and economic importance, no equine-specific vaccine is commercially available. Recombinant subunit vaccines are a safe and scalable alternative; however, their immunogenicity often requires improvement. Probiotic supplementation with Bacillus toyonensis may act as an immunomodulatory strategy to potentiate vaccine efficacy. This study aimed to evaluate the immunogenicity of a recombinant protein ...
Vaccination-associated lameness in warmblood horses after intramuscular injection.
Journal of equine veterinary science    February 23, 2026   Volume 159 105820 doi: 10.1016/j.jevs.2026.105820
Lenarz J, Smit IH, Rhodin M, Lischer C, Fugazzola MC.Intramuscular vaccination is a routine component of equine medicine, but local muscle soreness may transiently affect gait symmetry. Objective data on vaccination-associated gait changes in horses are lacking. Objective: To investigate whether intramuscular vaccination induces measurable gait asymmetries depending on injection site, to inform recommendations on vaccination site selection and short-term exercise management. Methods: In this prospective, randomised, blinded, placebo-controlled study, eighteen clinically sound Warmblood horses were enrolled and received an intramuscular vaccinati...
Molecular characterization and phylogeography of equine influenza virus H3N8 detected in donkeys in Nigeria 2022-2023.
BMC veterinary research    February 3, 2026   doi: 10.1186/s12917-025-05279-6
Mkpuma N, Meseko C, Shittu I, Chukwu C, Afiukwa FN, Iroha IR, Muhammad M, Ogbu O.Equine influenza virus (EIV) H3N8 is a highly contagious respiratory pathogen that poses significant health and economic risks to equids globally. In southeastern Nigeria where equids are sold and slaughtered, limited data exist on EIV epidemiology and circulating lineages. Methods: To address this gap, an active surveillance was conducted between January 2022 and October 2023. A total of 400 nasal swabs were collected from horses and donkeys at slaughterhouses and animal markets. The swabs were screened for equine influenza virus (EIV) using quantitative Reverse-Transcription Polymerase Chain...
Serological Assays to Measure Rabies Antibody Response in Equine Serum Samples.
Viruses    January 14, 2026   Volume 18, Issue 1 108 doi: 10.3390/v18010108
Beniwal N, Lal B, Mithina S, Verma CK, Kumar S, Phagna V, Jakhar K, Sonar S, Gupta V, Singh R, Kumar N, Tan CW, Thachamvally R, Singha H, Murzello K....Rabies is a neglected tropical zoonotic disease caused by rabies-virus (RV) infection and is responsible for almost 60,000 annual deaths globally, largely affecting the socio-economically disadvantaged population. Although fatality is preventable by immunization either before or after exposure with therapeutic antibodies, the high cost of prophylaxis or treatment limits their accessibility for the affected population. However, due to the almost 100% fatality rate in symptomatic individuals, almost 29 million annual vaccinations are performed, imposing high financial burden. Human transmission ...
Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.
Biotechnology reports (Amsterdam, Netherlands)    January 12, 2026   Volume 49 e00946 doi: 10.1016/j.btre.2026.e00946
Varela V, Costa M, Maciel C, Barbeito J, Barrera EE, Gutierre E, Correa A, Elgue M, Carrasco S, Larrosa MD, Pereira M, Correa J, Crosignani N....Anti-NGF monoclonal antibodies have recently been approved for treating degenerative joint disease, including osteoarthritis pain, in dogs and cats. However, their widespread use is limited by high cost and the requirement for repeated injections. Nerve Growth Factor and Substance P play central roles in the initiation and maintenance of inflammation and chronic pain in OA. There is a pressing need for new, safe, cost-effective therapies that target the underlying mechanisms of OA chronic pain. Here, we designed and produced a novel recombinant fusion protein, termed rNGFSP, which functions as...
Evaluating the Biochemical and Haematological Safety of the Histoplasma capsulatum var. farciminosum ‘8ZH’ Vaccine in Foals.
Veterinary medicine and science    January 7, 2026   Volume 12, Issue 1 e70764 doi: 10.1002/vms3.70764
Epizootic lymphangitis (EEL), caused by Histoplasma capsulatum var. farciminosum (HCF), is a neglected equine fungal disease lacking effective vaccines. The newly developed inactivated '8ZH' vaccine requires safety validation in the target species. Objective: To evaluate the biochemical, haematological and clinical safety of the inactivated HCF '8ZH' vaccine in foals. Methods: A controlled, single-blinded study was conducted on 30 clinically healthy foals (4-6 months), randomized into vaccinated (n = 15) and control (n = 15) groups. Vaccinated animals received a 5 mL intramuscular dose (...
Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse.
Animals : an open access journal from MDPI    December 13, 2025   Volume 15, Issue 24 3584 doi: 10.3390/ani15243584
Rask E, Righetti F, Ruiz A, Bjerketorp J, Frosth S, Frykberg L, Jacobsson K, Guss B, Flock JI, Henriques-Normark B, Hartman E, Gustafsson A....Infection of susceptible horses with subspecies (), the causative agent of strangles, is associated with commingling. Exposure may occur among horses at equestrian events, sales, or horses moved among different equine stabling environments. Strangles can affect all horses on a farm, leading to the death of up to 10% of cases depending on their immunity status at the time of infection, the development of complications, the success of biosecurity measures, and the use of vaccination. The current retrospective study used ELISAs to measure the exposure of horses to at a farm that experienced an...
Geographic diversity of the Streptococcus equi subsp. equi accessory genome: implications for vaccines and global surveillance.
Frontiers in veterinary science    November 28, 2025   Volume 12 1721958 doi: 10.3389/fvets.2025.1721958
He L, Khine NO, Song J, Loubière C, Butaye P.Strangles, caused by the host-adapted subsp. (. ), imposes significant welfare and economic losses on the equine industry worldwide. Understanding its genomic features, virulence-associated genes (VAGs), antimicrobial resistance (AMR) and mobile genetic elements (MGEs) is essential for disease control and vaccine development. This study aimed to characterize the accessory genome composition, geographic distribution of VAGs and MGEs, and AMR profiles of . by a large-scale genomic analysis of global publicly available . sequences. All publicly available . sequences in the Sequence Read Arch...
Reining in strangles: Absence of disease in horses vaccinated with a DIVA-compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi.
Equine veterinary journal    November 23, 2025   Volume 58, Issue 2 476-485 doi: 10.1111/evj.70125
Gröndahl G, Righetti F, Aspán A, Bjerketorp J, Frosth S, Frykberg L, Jacobsson K, Guss B, Paillot R, Flock JI, Henriques-Normark B, Waller AS.Strangles, caused by Streptococcus equi subspecies equi (S. equi), is a prevalent infectious disease of horses. This is the first report on the use of a new vaccine, Strangvac, in a natural outbreak of strangles. Objective: To measure the effects of Strangvac vaccination during an outbreak of strangles at a Swedish farm. Methods: Longitudinal cohort study. Methods: Healthy horses (n = 17) were vaccinated on day 0, which occurred 23 days after strangles was first confirmed in three unvaccinated horses on the same farm. Blood serum samples were collected on day 0, day 28 and day 489. A com...
Neutralisation of the Immunoglobulin-Cleaving Activity of Streptococcus equi Subspecies equi IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine.
Vaccines    October 17, 2025   Volume 13, Issue 10 1061 doi: 10.3390/vaccines13101061
Righetti F, Hentrich K, Flock M, Frosth S, Jacobsson K, Bjerketorp J, Pathak A, Ido N, Henriques-Normark B, Frykberg L, Paillot R, Guss B, Wood T.... subspecies () is the cause of strangles, one of the most prevalent diseases of horses worldwide. The disease is characterised by fever and the formation of abscesses in the lymph nodes of the head and neck, which can restrict the airway. A multicomponent subunit vaccine, Strangvac, has been shown to effectively reduce clinical signs of strangles and to reduce its incidence. The aim of this study was to determine the immune response against the immunoglobulin-cleaving endopeptidase IdeE, a key protective component within the vaccine and the ability of antibodies to neutralize the proteolytic...
Corrigendum to “Development of African horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes” [Vaccine 64 (2025) 127772].
Vaccine    October 14, 2025   Volume 66 127839 doi: 10.1016/j.vaccine.2025.127839
van Rijn PA, Wernery U, Feddema AJ, Maris-Veldhuis MA, Joseph S, van Gennip RGP.No abstract available
Autologous Cancer Vaccines: A Precision Immunotherapy Strategy for Veterinary Cancer Patients.
Anticancer research    September 27, 2025   Volume 45, Issue 10 4115-4130 doi: 10.21873/anticanres.17766
Greenberg CB, Suckow MA, Clauson RM, Kalinauskas AE, Lucroy MD.Precision medicine is a therapeutic strategy to provide treatment that is tailored to a specific patient based on factors unique to that individual, such as the genetic makeup or the environment. Autologous cancer vaccines (ACVs) are ideal for a precision medicine approach because they incorporate antigens specific to the patient's tumor and provide an elegant solution to identifying and selecting relevant immunogenic neoantigens. ACVs are an appealing option for veterinary medicine because they are cancer-type and species agnostic. Over the past 50 years, many innovative ACVs have been evalua...
Development of African horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes.
Vaccine    September 23, 2025   Volume 64 127772 doi: 10.1016/j.vaccine.2025.127772
van Rijn PA, Wernery U, Feddema AJ, Maris-Veldhuis MA, Joseph S, van Gennip RGP.African Horse Sickness (AHS) is a devastating vector-borne viral disease of equids with a mortality up to 95 % in naïve domestic horses. The causative African horse sickness virus (AHSV) is a distinct species of the genus Orbivirus of the family Sedoreoviridae, consisting of nine serotypes showing limited cross protection. AHSV is transmitted by Culicoides biting midges. Outbreaks cause huge economic losses in developing African countries. AHS has become a serious threat for countries outside Africa, since endemic Culicoides species in moderate climates appear competent vectors of the closel...
Vaccination against Hendra virus of previously unvaccinated mares and their foals demonstrates the effectiveness of the current prime and boost vaccination schedule for foals.
Veterinary microbiology    September 15, 2025   Volume 310 110732 doi: 10.1016/j.vetmic.2025.110732
Carey KJ, Smith I, Hartley CA, Bailey KE, McIntosh K, Broder CC, Gilkerson JR.Hendra virus (HeV) is a high consequence pathogen that causes severe respiratory and/or neurological disease in both horses and humans with high mortality. The equine vaccine, Equivac® HeV, is a recombinant soluble version of the G glycoprotein of HeV (HeV-sG) that elicits a potent HeV-neutralising antibody response in adult horses and also provides indirect protection for humans. Maternally derived HeV-G specific antibodies could interfere with subsequent foal vaccination, although other factors such as foal age and the suitability of vaccination protocols that have been optimised for adult ...
The Viremic Phase and Humoral Immune Response Against African Horse Sickness Virus That Emerged in Thailand in 2020.
Veterinary sciences    September 11, 2025   Volume 12, Issue 9 878 doi: 10.3390/vetsci12090878
Pipitpornsirikul P, Thangthamniyom N, Laikul A, Songkasupa T, Pathomsakulwong W, Apichaimongkonkun T, Kasemsuwan S, E-Kobon T, Lekcharoensuk P.African horse sickness (AHS), a life-threatening disease caused by African horse sickness virus serotype 1 (AHSV-1), emerged in Thailand in February 2020 with 607 cases and a 93% fatality rate. The outbreak was mitigated by vector control and a live attenuated virus (LAV) vaccine. Information regarding viremia and immunity after infection and vaccination during outbreaks are essential for controlling disease transmission. This study evaluated these parameters in 15 infected naïve horses and 11 vaccinated horses during the 2020 outbreak. Whole blood was collected and subjected to RT real-time ...
Adjuvant combination enhances immune response of equine influenza virus vaccine in horses.
Equine veterinary journal    September 2, 2025   Volume 58, Issue 2 591-600 doi: 10.1111/evj.70090
Dong-Ha L, Eun-Bee L, Jong-Pil S, Eun-Ju K.Despite routine vaccination, equine influenza outbreaks occur due to disparities of virus strains between vaccine and field, and immunity gaps between vaccinations. Objective: To evaluate whether a combination of adjuvants can enhance immune responses to equine influenza virus (EIV) vaccines. Methods: In vivo experimental study. Methods: Eight mixed-breed horses were immunised intramuscularly with a recombinant canarypox-based EIV vaccine, either alone or in combination with monophosphoryl lipid A (MPL) and polyinosinic-polycytidylic acid (poly I:C). A single vaccine dose was administered, and...
Genetic and serological analyses of equine influenza viruses isolated in Kumamoto and Hokkaido, Japan in 2025.
Veterinary microbiology    August 30, 2025   Volume 310 110701 doi: 10.1016/j.vetmic.2025.110701
Nemoto M, Kawanishi N, Kamei R, Furusho K, Kawauchi K, Yabuuchi Y, Oue Y, Uchida Y, Nishiura H, Reedy SE, Chambers TM, Li F, Bannai H, Yamanaka T....In April and May 2025, outbreaks of equine influenza occurred for the first time in 17 years in Japan. Equine influenza virus (EIV) of the H3N8 subtype was mainly detected in heavy draft horse populations in Kumamoto Prefecture and the Tokachi area of Hokkaido. In total, 10 EIVs were isolated from infected horses and then were used for genetic and serological analyses. Phylogenetic analysis of all eight genes revealed that all Japanese isolates were clustered with the Florida sublineage clade 1 (Fc1) viruses and were closely related to North American Fc1 viruses detected in 2024-2025. The resu...
Integration of empirical network data and agent-based modelling to examine the risk of equine influenza infection in equine athletes in Ontario, Canada.
Preventive veterinary medicine    August 26, 2025   Volume 245 106665 doi: 10.1016/j.prevetmed.2025.106665
Turcotte G, O'Sullivan TL, Rossi TM, Spence KL, Winder CB, Greer AL.Horses are frequently transported, creating opportunities for the spread of pathogens. Disease transmission models for equine infectious diseases face limitations on their generalizability due to challenges in describing equine movement and the structure of their contact networks beyond simplistic assumptions. This study aimed to combine a stochastic, agent-based, SEIR model for equine influenza disease dynamics with an observed Ontario, Canada equine contact network structure to quantify the potential magnitude of equine influenza outbreaks in Ontario competition horses under different condit...
V4020 Venezuelan Equine Encephalitis Vaccine: Mitigating Neuroinvasion and Reversion Through Rational Design.
Viruses    August 19, 2025   Volume 17, Issue 8 1136 doi: 10.3390/v17081136
Centers A, Barnaby K, Goedeker S, Pignataro A, Tretyakova I, Lukashevich I, Pushko P, Chung D.There is a need for safe and effective vaccines against the Venezuelan equine encephalitis virus that infects both humans and equines. However, development of a live-attenuated vaccine using the TC-83 strain has been hampered by substantial reactogenicity and the potential for neuroinvasion. In this study, we demonstrate that V4020, a new TC-83-based investigational VEEV vaccine with redundant safety features preventing neuroinvasion and reversion, exhibited no neuroinvasion potential in a murine model. Following subcutaneous or intramuscular administration, a subset of mice that received the ...
Development of an African horse sickness VP6 DIVA diagnostic ELISA.
Virology journal    August 12, 2025   Volume 22, Issue 1 276 doi: 10.1186/s12985-025-02898-1
Tinarwo M, Dennis SJ, Hitzeroth II, Meyers AE, Rybicki EP, Mbewana S.African horse sickness (AHS) is a severe, noncontagious disease of equines caused by the African horse sickness virus (AHSV). The virus has nine serotypes and is transmitted by the midge. AHS is endemic in South Africa and other sub-Saharan African countries. Currently, the disease is managed using a live attenuated vaccine manufactured by Onderstepoort Biological Products (OBP). Although this vaccine has been in use for decades, it has several drawbacks, including the possibility of reversion to virulence, and it does not allow for the differentiation of infected horses from vaccinated horse...
Long-Term Maintenance of High Neutralizing Anti-SARS-CoV-2 Antibodies Titres in Mares’ Milk and Offspring Serum After Pregnant Mares Immunization With SARS-CoV-2 Spike Protein.
Veterinary medicine and science    July 23, 2025   Volume 11, Issue 5 e70488 doi: 10.1002/vms3.70488
Roncaglia-Pereira VA, Dumard CH, Monteiro-Machado M, Melo PA, Fonseca J, Meirelles L, Cunha-Ribeiro L, Souza P, da Silva JL, Castilho L....In this study, we aim to report the persistent presence of anti-SARS-CoV-2 immunoglobulins in pre-immunized mare offspring. Three mares from Vital Brazil Institute were pre-immunized with recombinant SARS-CoV-2 spike protein and became pregnant during this period. After parturition, the mares' serum and colostrum/milk and foal serum were collected over 6 weeks. Our results have shown high and persistent presence of IgG and neutralizing antibodies over the weeks not only in the mares' serum, as expected, but in mares' colostrum/milk and foal serum as well-what were very surprising. This peculia...
Seroprevalence of Equine Influenza Virus Antibodies in Horses from Four Localities in Colombia.
Viruses    July 16, 2025   Volume 17, Issue 7 999 doi: 10.3390/v17070999
Gonzalez-Obando J, Jaimes-Dueñez J, Zuluaga-Cabrera A, Forero JE, Diaz A, Rojas-Arbeláez C, Ruiz-Saenz J.Equine influenza is a highly contagious disease caused by the equine influenza virus (EIV). The occurrence of EIV outbreaks in America is associated with low levels of vaccination coverage. In Colombia, no seroprevalence evaluation has been carried out to estimate the distribution of the virus within the country. Our aim was to perform a sero-epidemiological survey of equine influenza infections and to identify associated risk factors in horses from four departments of Colombia. Serological testing was carried out by using an ELISA for the detection of IgG antibodies against the influenza A vi...
Growth properties of recombinant equine influenza viruses with different backbones generated by reverse genetics in embryonated chicken eggs.
Archives of virology    July 12, 2025   Volume 170, Issue 8 181 doi: 10.1007/s00705-025-06368-5
Nemoto M, Kawanishi N, Kambayashi Y, Bannai H, Yamanaka T, Garvey M, Cullinane A, Yamayoshi S, Kawaoka Y, Tsujimura K.Reverse genetics (RG) technology is useful for quickly updating influenza vaccine strains. A high-yield backbone (i.e., six segments other than hemagglutinin and neuraminidase) derived from A/Puerto Rico/8/1934 (PR8) has been developed to improve the growth of avian and human influenza viruses. However, for equine influenza virus (EIV), an EIV-derived backbone may have better growth properties due to more-natural segment combinations. We compared the growth properties in eggs between the PR8 backbone and an EIV backbone from A/equine/Ibaraki/1/2007, a vaccine strain in Japan. The results showe...
Rabies in livestock in the United States (2012-2021).
American journal of veterinary research    June 30, 2025   1-8 doi: 10.2460/ajvr.25.01.0019
Payette-Stroman A, Ross Y, Ma X, Boutelle C, Holschbach C, Blanton JD, Wallace R.Rabies in livestock in the United States (US) poses a significant public health concern due to the potential for human exposure and economic losses to producers. Understanding the epidemiology of rabies in livestock supports broader One Health goals by enhancing early detection of viral incursions and protecting both animal and human health. This study assessed the epidemiology of rabies in livestock in the US from 2012 to 2021 using surveillance data reported to the National Rabies Surveillance System. A sensitivity analysis was conducted to estimate economic losses, including livestock value...
Reduction in endemic equine herpesvirus type-1 and type-4 infection among Thoroughbred yearlings through an updated vaccination program.
Journal of equine science    June 12, 2025   Volume 36, Issue 2 67-74 doi: 10.1294/jes.36.67
Bannai H, Kambayashi Y, Kume K, Takebe N, Endo Y, Kawanishi N, Nemoto M, Tsujimura K.The endemic situation of respiratory disease caused by equine herpesvirus type-1 (EHV-1) and type-4 (EHV-4) was investigated in a training facility for Thoroughbred yearlings in Japan. Vaccination typically starts in mid-September or early October-only after all yearlings have arrived-leaving those introduced earlier unprotected. To bridge this immunity gap, a revised vaccination program that started earlier was implemented. In 2021-2022 and 2022-2023, yearlings were allocated to three groups according to their introduction dates. Each group received a live EHV-1 vaccine (Equi N Tect ERP, Niss...
Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4).
Vaccines    May 31, 2025   Volume 13, Issue 6 604 doi: 10.3390/vaccines13060604
Kutumbetov L, Myrzakhmetova B, Tussipova A, Zhapparova G, Tlenchiyeva T, Bissenbayeva K, Nurabayev S, Kerimbayev A.Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no licensed monovalent vaccine for EHV-4, and existing formulations offer limited protection against this serotype. This study aimed to develop and evaluate a freeze-dried, live-attenuated EHV-4 vaccine with improved safety, stability, and immunogenicity. Methods: A field isolate of EHV-4 was attenuated through serial passaging in ...
Enteral immunization with live bacteria reprograms innate immune cells and protects neonatal foals from pneumonia.
Scientific reports    May 25, 2025   Volume 15, Issue 1 18156 doi: 10.1038/s41598-025-02060-5
da Silveira BP, Kahn SK, Legere RM, Bray JM, Cole-Pfeiffer HM, Golding MC, Cohen ND, Bordin AI.Using a horse foal model, we show that enteral immunization of newborn foals with Rhodococcus equi overcomes neonatal vaccination challenges by reprogramming innate immune responses, inducing R. equi-specific adaptive humoral and cell-mediated immune responses and protecting foals against experimental pneumonia challenge. Foals were immunized twice via gavage of R. equi (immunized group) or saline (control group) at ages 1 and 3 days. At age 28 days, all foals were challenged intrabronchially with R. equi. Post-challenge, all 5 immunized foals remained healthy, whereas 67% (4/6) of control foa...
Equine viral arteritis: Seroprevalence patterns and risk factors in equids from western Europe.
Research in veterinary science    May 19, 2025   Volume 192 105701 doi: 10.1016/j.rvsc.2025.105701
Franco JJ, Gonzálvez M, Cano-Terriza D, Barbero-Moyano J, Jose-Cunilleras E, Alguacil E, García J, García-Bocanegra I.Equine viral arteritis is a notifiable infectious disease with sanitary and economic implications at a global scale. A cross-sectional serosurvey was performed to determine the exposure of equids to the Alphaarterivirus equid [Equine Arteritis Virus (EAV)] in three regions in western Europe. Serum samples from 1425 equids (1196 horses, 104 donkeys, and 125 mules/hinnies) from Catalonia (northeastern Spain), Andalusia (southern Spain) and southeastern United Kingdom (UK) were collected during the period 2011-2023. The overall EAV seroprevalence in EAV-unvaccinated equids was 9.7 % (138/1425; 9...
Establishment of an In-House Indirect Enzyme-Linked Immunosorbent Assay to Detect Antibodies Against African Horse Sickness Based on Monovalent and Polyvalent Live Attenuated Vaccines During the First Outbreak in Thailand.
Animals : an open access journal from MDPI    May 15, 2025   Volume 15, Issue 10 doi: 10.3390/ani15101433
Punyadarsaniya D, Taesuji M, Rattanamas K, Ruenphet S.Standard serological tests post-vaccination, such as enzyme-linked immunosorbent assay (ELISA), complement fixation, and virus neutralization, are crucial for monitoring African horse sickness (AHS). However, the availability of commercial test kits such as blocking ELISA varies by regions; while they are commonly used in Africa and Europe, their limited availability and high cost in Thailand present significant challenges. Therefore, this study aimed to evaluate an alternative approach using an in-house indirect ELISA based on cell-based monovalent and polyvalent strains of live attenuated AH...
Comparison of the efficacies of Rhodococcus equi recombinant vaccine in mice.
Veterinary research forum : an international quarterly journal    May 15, 2025   Volume 16, Issue 5 253-259 doi: 10.30466/vrf.2024.2028438.4266
Golen GS, Erganiş O, Balevi A. is an important bacterial pathogen and causes severe chronic granulomatous pneumonia in foals below 6 months of age. It has also become an opportunistic and emerging pathogen in immunocompromised humans. Vaccination is the most cost-effective strategy for controlling and preventing this infection. Although several potential virulence genes and candidate immunogens have been identified over the years, no effective vaccine is currently available to prevent disease in horses. Recently, bacterial vector vaccines have been shown to be promising for In this study, the gene of was cloned into P...
1 2 3 29